Canadian Journal of Diabetes
Canadian Journal of Diabetes is Canada’s only diabetes-oriented, peer-reviewed, interdisciplinary journal for diabetes healthcare professionals.
Published quarterly (February, April, June, August, October and December), Canadian Journal of Diabetes contains original articles, resource reviews, a journal watch, shorter articles such as Perspectives in Practice and Diabetes and Society, and news from the Clinical and Scientific Section and the Diabetes Educators Section of the Canadian Diabetes Association.
Canadian Journal of Diabetes is distributed as a benefit of membership to all members of the Professional Sections of Canadian Diabetes Association.
Declaration of Conflict of Interest at Canadian Journal of Diabetes
Declaration of Conflict of Interest at Canadian Journal of Diabetes
H.J. Dean
Bridging the Gap: Transition From Pediatric to Adult Diabetes Care
Bridging the Gap: Transition From Pediatric to Adult Diabetes Care
N. Van Walleghem
The Role of the Glycemic Index in Diabetes Management: How Practical Is It?
The Role of the Glycemic Index in Diabetes Management: How Practical Is It?
S. Ludwig
Problems in Transition From Pediatric Care to Adult Care for Individuals With Diabetes
Patients with diabetes should take an active role in the management of their disease.
D. Pacaud, J.-F. Yale, D. Stephure, R. Trussell, H.D. Davies
UCP2 Knockout Mouse Islets Have Lower Consumption and Faster Oscillations of Beta Cell Oxygen
The pancreatic beta cell is a key player in regulating plasma glucose levels.
J.W. Joseph, C.B. Chan, M.B. Wheeler
The Role of the Glycemic Index in the Prevention and Management of Diabetes: A Review and Discussion
The goal of the clinical management of type 1 and type 2 diabetes is to control metabolic abnormalities in order to prevent both acute (hyperglycemia, hypoglycemia) and long-term (retinopathy, nephropathy, neuropathy, cardiovascular disease [CVD]) complications without negatively affecting quality of life (1).
M. Kalergis, E. De Grandpré, C. Andersons
The Role of Islet Amyloid Polypeptide in Type 2 Diabetes
Type 2 diabetes mellitus is characterized by impairment in insulin action (insulin resistance) and insulin secretion (beta cell dysfunction), which arise from both genetic defects and environmental influences (1-6).
L. Marzban, C.B. Verchere
Detection and Enumeration of Beta Cell-Specific Cytotoxic T Lymphocytes in Type 1 Diabetes: Is Disease Prediction Possible?
Type 1 diabetes mellitus is an autoimmune disease that culminates in the near-complete destruction of pancreatic beta cells and a life-long dependence on exogenous insulin.
J.D. Trudeau, C. Panagiotopoulos, C.B. Verchere, R. Tan
Production of materials has been made possible through a financial contribution from the Public Health Agency of Canada.
© 2012 Copyright Canadian Diabetes Association